Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates.
NEPA (Netupitant/Palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough CINV in Cycle 1 of Chemotherapy: A Phase II Clinical Trial.
Rolapitant for the treatment of chemotherapy-induced nausea and vomiting.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rolapitant for the treatment of chemotherapy-induced nausea and vomiting.
Rolapitant for the treatment of chemotherapy-induced nausea and vomiting. Expert Rev Anticancer Ther. 2015; 15(10):1127-33.
View in:
PubMed
subject areas
Animals
Antiemetics
Antineoplastic Agents
Humans
Morpholines
Nausea
Neurokinin-1 Receptor Antagonists
Pyridines
Quality of Life
Spiro Compounds
Vomiting
authors with profiles
Rudolph Navari